VIVUS to Present at Upcoming Investor Conference

| Source: VIVUS, Inc.

MOUNTAIN VIEW, Calif., Jan. 13, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment conference:

32nd Annual J.P. Morgan Healthcare Conference
January 15, 2014, 3:30pm PST
Westin St. Francis Hotel, San Francisco, California

A live webcast and 30-day archive of the presentation will be available at


VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ending December 31, 2012, as amended by the Form 10-K/A filed on April 30, 2013 and by the Form 10-K/A filed on June 12, 2013, and periodic reports filed with the Securities and Exchange Commission.

Dana B Shinbaum
Corporate Development & Investor Relations

Investor Relations:
The Trout Group
Brian Korb